Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data
Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data
批准号:
453432
负责人:
Wong William Wai Lun
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-06-01 至 2022-06-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hepatitis B virus (HBV) is one of the most burdensome infectious diseases and one of the most expensive infectious diseases to prevent and treat. HBV infection can cause chronic infection of the liver (i.e. chronic hepatitis B (CHB)), that is silent for 2
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards establishing accurate estimates of national chronic hepatitis B prevalence and undiagnosed proportion in Canada
-
批准号:488763
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Wong William Wai Lun
-
依托单位:
Developing policy models for sexually transmitted and blood-borne infection: integrating best evidence of effectiveness, safety, cost, and patient preferences
-
批准号:499040
-
项目类别:Salary Programs
-
资助金额:$83.78万
-
财政年份:2023
-
负责人:Wong William Wai Lun
-
依托单位:
Evaluating the impact of direct-acting antiviral treatment access policy on chronic hepatitis C prevalence and the undiagnosed proportion
-
批准号:475136
-
项目类别:Operating Grants
-
资助金额:$10.93万
-
财政年份:2022
-
负责人:Wong William Wai Lun
-
依托单位:
Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting
-
批准号:456739
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2021
-
负责人:Wong William Wai Lun
-
依托单位:
Understanding the treatment benefits of chimeric antigen receptor T-cells for lymphoma: quality of life, health utility, cost, and return to work
-
批准号:438086
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2020
-
负责人:Wong William Wai Lun
-
依托单位:
Towards eliminating viral hepatitis - Addressing hepatitis B using a multidisciplinary approach
-
批准号:414585
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2019
-
负责人:Wong William Wai Lun
-
依托单位:
Understanding the treatment benefits of novel antiviral agents for hepatitis C: quality of life, health utility, cost, and return to work
-
批准号:346614
-
项目类别:Operating Grants
-
资助金额:$34.25万
-
财政年份:2016
-
负责人:Wong William Wai Lun
-
依托单位:
Cross sectional and longitudinal measures of quality of life and utility among patients with chronic hepatitis C virus infection
-
批准号:310025
-
项目类别:Operating Grants
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Wong William Wai Lun
-
依托单位:
海外基金